Data gathered: May 29
AI Stock Analysis - Schrodinger (SDGR)
Analysis generated May 6, 2025. Powered by Chat GPT.
Schrodinger, Inc. is a leader in the field of computational drug discovery and materials science. Founded in 1990, the company specializes in the development and application of advanced computational methods to accelerate the discovery of new therapeutics and materials. With a robust platform that integrates predictive modeling, data analytics, and machine learning, Schrodinger aims to transform the landscape of drug discovery and development, reducing costs and timelines while improving success rates.
Stock Alerts - Schrodinger (SDGR)
 |
Schrodinger | May 27 Employee Rating is down by 2.2% over the last month. |
|
Schrodinger | May 20 Price is down by -10.8% in the last 24h. |
|
Schrodinger | May 6 Price is down by -7.2% in the last 24h. |
|
Schrodinger | April 16 Price is down by -7.4% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Schrodinger
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 33 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 108,000 | Sign up | Sign up | Sign up |
| Employee Rating | 88 | Sign up | Sign up | Sign up |
| Google Trends | 98 | Sign up | Sign up | Sign up |
| Patents | 4 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 28 | Sign up | Sign up | Sign up |
| Facebook Followers | 583 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,533 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 10 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,201 | Sign up | Sign up | Sign up |
| Twitter Mentions | 30 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 88 | Sign up | Sign up | Sign up |
| Linkedin Employees | 996 | Sign up | Sign up | Sign up |
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.
| Price | $21.52 |
| Target Price | Sign up |
| Volume | 976,730 |
| Market Cap | $1.57B |
| Year Range | $16.98 - $26.54 |
| Dividend Yield | 0% |
| PE Ratio | 46.78 |
| Analyst Rating | 71% buy |
| Industry | Drug Manufacturers |
In the news
Schrodinger to Present at Jefferies Global Healthcare ConferenceMay 22 - Finnhub |
|
Schrodinger Inc Says Schrödinger Restructures Operations To Reduce Workforce And Costs - SEC FilingMay 19 - Finnhub |
|
 |
Q1 2025 Schrodinger Inc Earnings CallMay 7 - Yahoo |
Schrodinger Reports Strong First Quarter 2025 Financial ResultsMay 7 - Finnhub |
|
|
Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...May 7 - Yahoo |
|
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Tops Revenue EstimatesMay 7 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 60M | 28M | 31M | -60M | -51M | -0.640 |
| Q4 '24 | 88M | 24M | 64M | -40M | -19M | -0.240 |
| Q3 '24 | 35M | 18M | 18M | -38M | -67M | -0.523 |
| Q2 '24 | 47M | 16M | 31M | -54M | -51M | -0.740 |
| Q1 '24 | 37M | 18M | 19M | -55M | -66M | -0.760 |
Insider Transactions View All
| Akinsanya Karen filed to sell 15,625 shares at $25. April 15 '25 |
| Akinsanya Karen filed to sell 18,970 shares at $25.1. April 15 '25 |
| Akinsanya Karen filed to sell 23,970 shares at $25.1. April 15 '25 |
| Herman Jenny filed to sell 27,349 shares at $21.1. March 7 '25 |
| Porges Geoffrey Craig filed to sell 27,544 shares at $21.8. March 4 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$152.43 0% | 49 |
 |
Eli Lilly and CompanyLLY |
$719.39 0% | 70 |
 |
PfizerPFE |
$23.18 0% | 44 |
 |
AstrazenecaAZN |
$70.38 0% | 51 |
 |
AbbVieABBV |
$183.09 0% | 49 |
Read more about Schrodinger (SDGR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Schrodinger?
The Market Cap of Schrodinger is $1.57B.
What is Schrodinger's PE Ratio?
As of today, Schrodinger's PE (Price to Earnings) ratio is 46.78.
What is the current stock price of Schrodinger?
Currently, the price of one share of Schrodinger stock is $21.52.
How can I analyze the SDGR stock price chart for investment decisions?
The SDGR stock price chart above provides a comprehensive visual representation of Schrodinger's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Schrodinger shares. Our platform offers an up-to-date SDGR stock price chart, along with technical data analysis and alternative data insights.
Does SDGR offer dividends to its shareholders?
As of our latest update, Schrodinger (SDGR) does not offer dividends to its shareholders. Investors interested in Schrodinger should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Schrodinger?
Some of the similar stocks of Schrodinger are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.